← board
BKHAU
distress 1/10 · well-funded / low risk$12.030%today-18% from 52w high
Revenue
pre-revenue
Liquidity
$0M
Runway
—
Shares 1y
0%
Price & events
+2.8% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
-3.7%
1W
-0.7%
1M
+2.9%
3M
+2.8%
6M
+14.5%
1Y
+16.2%
2Y
—
5Y
+18.5%
All
Overview
- Market Cap
- $49.97M
- Volume
- 0
- 52 Week Range
- $10.51 – $14.69
- Total Shares
- 4.15M
- Float Shares
- 1.24M
- % Held by Insiders
- 0.00%
- % Held by Institutions
- 0.08%
- Beta
- 0.03
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.